Daewon Pharmaceutical Co., Ltd. (KRX: 003220)

Daewon Pharmaceutical Revenue

Daewon Pharmaceutical had revenue of 156.83B KRW in the quarter ending September 30, 2024, with 21.59% growth. This brings the company's revenue in the last twelve months to 593.94B, up 16.77% year-over-year. In the year 2023, Daewon Pharmaceutical had annual revenue of 526.95B with 10.04% growth.

• Revenue (ttm): 593.94B
• Revenue Growth: +16.77%
• P/S Ratio: 0.50
• Revenue / Employee: 471.38M
• Employees: 1,260
• Market Cap: 298.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	526.95B	48.07B	10.04%
Dec 31, 2022	478.88B	124.71B	35.21%
Dec 31, 2021	354.18B	45.68B	14.81%
Dec 31, 2020	308.50B	-9.33B	-2.93%
Dec 31, 2019	317.83B	31.18B	10.88%